PETALING JAYA: Doctors should restrict their prescription of anti-diabetes medicine rosiglitazone and not start it on new patients following fears that it may increase cardiovascular problem.
The Drug Control Authority said diabetic patients who were put on the drug should also seek their doctors’ advice on whether they should continue with it.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!